Aurinia Pharmaceuticals Inc AUPH

$16.57 +0.76% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-09-11 View →
4 FORM 4 2026-08-25 View →
8-K 8-K 2026-08-19 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-06-08 View →
4 FORM 4 2026-06-08 View →
4 FORM 4 2026-06-08 View →
4 FORM 4 2026-06-08 View →
8-K 8-K 2026-06-04 View →
4 Insider transaction 2026-06-02 View →
4 FORM 4 2026-05-20 View →
4 FORM 4 2026-05-20 View →
4 FORM 4 2026-05-20 View →
8-K 8-K 2026-05-11 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-21 View →
8-K 8-K 2026-04-03 View →
8-K 8-K 2026-03-23 View →
4 FORM 4 2026-03-10 View →
4 Insider transaction 2026-03-03 View →
4 FORM 4 2026-03-03 View →
4 FORM 4 2026-03-03 View →
4 FORM 4 2026-03-03 View →
4 FORM 4 2026-03-03 View →
4 FORM 4 2026-03-03 View →
10-K 10-K 2026-02-26 View →
8-K 8-K 2026-02-26 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-03 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2026-01-05 View →
4 FORM 4 2025-11-24 View →
4 FORM 4 2025-11-24 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$16.57
Market Cap
$2.19 billion
52-Week Range
$10.34 – $19.25
Average Volume
896K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.